Minhui Chen, Xinpei Wang, Lena Krockenberger, Rika Tyebally, Jeremy J. Berg, Sebastian Pott, Jonathan Flint, Joseph E. Powell, Brunilda Balliu, Xuanyao Liu, Andy Dahl
6 min
Connecting genetic variants to complex traits remains a major challenge in human genetics. While bulk tissue studies have identified many expression quantitative trait loci (eQTLs), these known effects explain only a small fraction of the heritability of complex traits. This study investigates whether this gap exists because standard bulk-tissue approaches are biased toward detecting large, cell-type-shared eQTLs, while the regulatory effects relevant to complex traits are actually cell-type-specific.
The authors developed a statistical framework called CIGMA (cell-type-informed genetic mixed-model analysis) to unbiasedly quantify the variance explained by cell-type-shared and cell-type-specific eQTLs using population-scale single-cell RNA-sequencing (scRNA-seq) data. Unlike methods that focus on identifying individual significant variants, CIGMA partitions the overall genetic variance of gene expression. The researchers applied this model to the OneK1K cohort (peripheral blood mononuclear cells) and replicated their findings in a second dataset (CLUES and ImmVar), ensuring robustness across different ancestries and health states.
The study demonstrates that cell-type-specific eQTLs are a fundamental feature of gene regulation, particularly for trans-acting effects, which are roughly 60% cell-type-specific compared to 30% for cis-acting effects. Crucially, these cell-type-specific eQTLs are enriched for complex trait heritability, whereas cell-type-shared eQTLs show no such enrichment. Furthermore, genes with higher eQTL specificity are associated with greater evolutionary constraint, higher enhancer complexity, and increased gene network connectivity—features that are known to be enriched in complex traits but depleted in standard bulk-tissue eQTL studies. These results suggest that bulk-tissue studies systematically bias discovery toward shared effects, thereby missing the regulatory architecture that drives disease risk.
This work provides a clear explanation for why known eQTLs have historically struggled to account for the genetic architecture of complex traits. By establishing that cell-type specificity is a key, robust feature of gene regulation, the study highlights the necessity of using single-cell resolution to map the regulatory landscape of human disease. It also provides a powerful, unbiased tool for future studies to quantify these effects without the limitations imposed by traditional detection-based methods.
Genetic effects on complex traits primarily act by regulating gene expression; however, this process is not well understood1. Studies of genetic effects on gene expression (expression quantitative trait loci (eQTLs)) can inform as to the gene regulatory layer between genetic variants and complex traits2. However, previous studies have not effectively captured cell-type-specific eQTLs, which are likely to be important for complex traits. Here we unbiasedly characterized cell-type-specific eQTLs by applying a variance component model to population-scale single-cell RNA-sequencing (RNA-seq) data. Using peripheral blood mononuclear cells from the OneK1K cohort, we demonstrated that cell-type-specific eQTLs enrich for complex trait heritability, which we did not observe for cell-type-shared eQTLs. We also found that eQTL specificity is associated with genes that have greater selective constraint, enhancer complexity and gene network connectivity, three features enriched in complex traits relative to known eQTLs3,4. Transcriptome-wide, trans eQTLs were mostly cell-type-specific (60% specific) whereas cis eQTLs were mostly shared (30% specific). We used a second single-cell RNA-seq dataset to replicate our findings and demonstrate that cell-type-shared and cell-type-specific eQTLs are consistent across ancestries. Our results establish eQTL cell-type specificity as a key feature of gene regulation and partly explain why known eQTLs are depleted in gene regulatory effects on complex traits. Single-cell RNA-sequencing shows that cell-type-specific expression quantitative trait loci drive much of complex trait heritability, highlighting cell-type-specific gene regulation as key to linking genetic variants with traits.
Alex: [analytical] What does the empirical application look like?
Sam: [grounded] They applied CIGMA to single-cell RNA-seq data from brain tissue, partitioning eQTL effects across major cell types—neurons, oligodendrocytes, astrocytes, microglia. The load-bearing finding is that a substantial fraction of eQTLs are cell-type-specific: strong effects in one cell type, near-zero in others. And those cell-type-restricted eQTLs are the ones enriched for heritability of neuropsychiatric traits and for signatures of purifying selection—exactly the variants you'd expect to matter biologically.
Alex: [probing] And those signals were invisible in the bulk analysis of the same tissue?
Sam: [quiet confidence] Largely, yes. When you run a standard bulk eQTL analysis on the same samples, those effects are attenuated or absent—because averaging across cell types dilutes a signal that's only present in, say, ten percent of the cells. CIGMA recovers them by modeling cell-type composition explicitly and estimating effects conditional on it. [[RP_SECTION:model-limitations|Model limitations]]
Alex: [deliberate] What are the honest limitations? Simulation results are reassuring, but simulations are designed to be recoverable.
Sam: [acknowledging the weight] The authors are fairly candid about two constraints. First, power. These are variance component estimates, and confidence intervals are wide at the sample sizes currently available in single-cell studies. The reported effect sizes should be read as conservative lower bounds—the true cell-type specificity is likely larger than what they detect. Second, the model assumes cell-type labels are accurate. If your clustering is wrong, or if you've lumped heterogeneous subtypes together, the delta parameter can't fully protect you—you're partitioning variance across categories that don't reflect the underlying biology. That's not a failure of CIGMA specifically, but it means the method's validity is coupled to the quality of upstream cell-type annotation.
Alex: [reflective] So the honest read is: a well-motivated and methodologically careful approach that recovers real signal, but the field is still sample-size-limited, and the results are only as good as the cell-type definitions feeding in.
Sam: [measured] That's right. The conceptual contribution is arguably as important as the specific estimates—demonstrating that cell-type specificity is a fundamental feature of gene regulation, not a secondary refinement. If that's correct, the bulk eQTL literature isn't just underpowered; it's asking the question at the wrong level of resolution. As single-cell cohorts scale up, the power constraints will ease, and the method is positioned to get more useful as the data improves. [[RP_SECTION:future-of-regulatory-genetics|Future of regulatory genetics]]
Alex: [considered] It reframes what we should expect from regulatory genetics—not one eQTL per gene, but a landscape of cell-type-conditional effects that bulk analyses were structurally unable to see.
Sam: [steady] Exactly. And that has downstream consequences for how we design fine-mapping studies, how we interpret GWAS colocalization, and ultimately how we connect regulatory variation to disease mechanism. The missing heritability problem may be less about the variants we haven't found and more about the resolution at which we've been looking. Thanks for listening to ResearchPod.